Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,200 | 148,090 | 103,496 | 65,056 | 29,673 |
| Depreciation Amortization | 3,100 | 10,156 | 7,286 | 4,540 | 1,892 |
| Income taxes - deferred | 14,603 | -39,922 | 54,807 | 33,517 | 14,138 |
| Accounts receivable | 2,009 | -3,927 | -10,357 | -2,561 | 834 |
| Other Working Capital | 7,951 | -60,068 | -68,149 | -50,618 | -25,493 |
| Other Operating Activity | 7,184 | 142,390 | 26,137 | 8,539 | -402 |
| Operating Cash Flow | $76,047 | $196,719 | $113,220 | $58,473 | $20,642 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42,272 | -165,904 | -101,515 | -50,846 | -20,111 |
| Purchase Of Investment | -248,000 | -1,514,475 | -1,164,667 | -650,532 | -196,079 |
| Sale Of Investment | 195,929 | 841,225 | 552,321 | 219,523 | 142,028 |
| Other Investing Activity | 0 | -17,498 | 0 | 0 | 0 |
| Investing Cash Flow | $-94,343 | $-856,652 | $-713,861 | $-481,855 | $-74,162 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 696,004 | 696,004 | 696,004 | N/A |
| Common Stock Issued | 4,278 | 23,059 | -118,597 | -122,025 | 9,147 |
| Common Stock Repurchased | N/A | -135,000 | N/A | N/A | N/A |
| Financing Cash Flow | $4,278 | $584,063 | $577,407 | $573,979 | $9,147 |
| Beginning Cash Position | 350,129 | 425,999 | 425,999 | 425,999 | 425,999 |
| End Cash Position | 336,111 | 350,129 | 402,765 | 576,596 | 381,626 |
| Net Cash Flow | $-14,018 | $-75,870 | $-23,234 | $150,597 | $-44,373 |
| Free Cash Flow | |||||
| Operating Cash Flow | 76,047 | 196,719 | 113,220 | 58,473 | 20,642 |
| Capital Expenditure | -42,272 | -165,904 | -101,515 | -50,846 | -20,111 |
| Free Cash Flow | 33,775 | 30,815 | 11,705 | 7,627 | 531 |